Methodist Health System
methodisthealth.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
169
Active
43
Phase 3
2
Total enrollment
4,863,006
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| pneumoniae bacteremia therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-06-23
Top conditions
- COVID-197
- Trauma7
- Obesity4
- Liver Diseases4
- Gastro-Intestinal Disorder3
- Cirrhosis3
- Gastrointestinal Disease2
- Diabetes2
Frequently asked questions about Methodist Health System
- How many clinical trials does Methodist Health System have on ClinicalTrials.gov?
- Methodist Health System is listed as the lead sponsor on 169 clinical trials in ClinicalTrials.gov, 43 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Methodist Health System's trials are in Phase 3?
- 2 of Methodist Health System's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Methodist Health System focus on?
- Methodist Health System's most-studied conditions on ClinicalTrials.gov are COVID-19, Trauma, Obesity, Liver Diseases, Gastro-Intestinal Disorder.
- When are Methodist Health System's next clinical trial readouts?
- Methodist Health System has 1 upcoming primary-completion readout tracked here; the soonest is “Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections”, expected around 2026-06-23.